Needle-free. No clinic required.
In Nigeria and other regions where distance and infrastructure limit access, Microneedle vaccine patches (MAPs) could bring vaccines closer to the people who need them most.
MAPs are an emerging vaccine delivery method designed to be painless, easy to apply, and stable without cold-chain requirements for extended periods. Instead of requiring trained healthcare workers and central clinics, MAPs can be self-administered or delivered by community health workers, reaching people directly where they are.
LunaVax is integrating MAPs into upcoming feasibility pilots to assess their impact alongside mobile vaccine vans and other supportive tools.
In regions where transportation, cold chain, lack of reliable records or identification, and staffing are major barriers, MAPs—especially when paired with tools like biometric identification—could transform coverage rates, closing gaps for rural villages, waterside communities, and urban areas with limited clinic access.
At LunaVax, we believe innovations like MAPs represent more than a new technology—they are a new opportunity for equity. By removing the needle and decentralizing delivery, MAPs can help bring vaccines within reach of every family.
A needle-free future. Access for every community.
Painless, needle-free vaccines that could help close last-mile gaps.
Read the full story from PATH →